The short version of hGH fragment fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-11-13 and is reviewed periodically as new material appears.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
of COVID-19 can be practiced based on information from the different populations in a community. Numerical solution is a commonly used method to analyze complicated kinetic networks when the analytical solution is difficult to obtain or limited by requirements such as boundary conditions or special parameters. It uses recursive equations to calculate the next step by converting the numerical integration into Riemann sum of discrete time steps e.g., use yesterday's principal and interest rate to calculate today's interest which assumes the interest rate is fixed during the day. The calculation contains projected errors if the analytical corrections on the numerical step size are not included, e.g. when the interest rate of annual collection is simplified to 12 times the monthly rate, a projected error is introduced. Thus the calculated results will carry accumulative errors when the time step is far away from the reference point and a convergence test is needed to estimate the error. However, this error is usually acceptable for data fitting. When fitting a set of data with a close time step, the error is relatively small because the reference point is nearby compared to when predicting a long period of time after a reference point. Once the real-time
The report also finds over 400,000 New Zealanders receiving welfare. McDonald's New Zealand is denied resource consent to build a restaurant in Wānaka due to strong local opposition. 13 February: The Public Service Association challenges Health New Zealand's proposed digital and IT job cuts, claiming they breached employment law. Crown Research Institute Callaghan Innovation proposes slashing 63 jobs in response to Government plans to disestablish the organisation. 14 February – Director-General of Health Diana Sarfati resigns. 15 February: A bush fire in North Canterbury causes a section of State Highway 7 to close and several homes to evacuate. Members of Destiny Church's "Man Up" group disrupt a "Pride and Rainbow" event at Te Atatū's library. The church's actions were condemned by Prime Minister Luxon, Mayor of Auckland Wayne Brown, Acting Waitematā District Commander Inspector Simon Walker and Labour leader Chris Hipkins. Foreign Minister Winston Peters announces that New Zealand will be considering the newly ratified Chinese–Cook Islands strategic partnership agreement in light of its national interests and constitutional relationship with the Cook Islands. 17 February: The New Zealand Police launch an investigation into assault complaints during a protest by Destiny Church members against a rainbow event at Te Atatū's library. Immigration New Zealand temporarily suspends deportation proceedings against New Zealand-born teenager Daman Kumar and his mother Sunita Devi (who both hold Indian citizenship) pending a ministerial review.
== Early life and education == Born in Aarberg, Switzerland, Wüthrich was educated in chemistry, physics, and mathematics at the University of Bern before pursuing his PhD supervised by Silvio Fallab at the University of Basel, awarded in 1964.
=== First women in space === The first woman in space was from the Soviet Union, Valentina Tereshkova. NASA did not welcome female astronauts into its corps until 1978, when six female mission specialists were recruited. This first class included scientist Sally Ride, who became America's first woman in space on STS-7 in June 1983. NASA included women mission specialists in the next four astronaut candidate classes, and admitted female pilots starting in 1990. Eileen Collins from this class became the first pilot to fly on Space Shuttle flight STS-63 in February 1995, and the first female commander of a spaceflight on STS-93 in July 1999. The USSR admitted its first female test pilot as a cosmonaut, Svetlana Savitskaya, in 1980. She became the first female to fly since Tereshkova, on Salyut 7 in December 1981.
Sources: en.wikipedia.org
=== Brazil === Absinthe was prohibited in Brazil until 1999 and was brought by entrepreneur Lalo Zanini and legalised in the same year. Presently, absinthe sold in Brazil must abide by the national law that restricts all spirits to a maximum of 54% ABV. While this regulation is enforced throughout channels of legal distribution, it may be possible to find absinthe containing alcohol in excess of the legal limit in some restaurants or food fairs.
copper toxicity / zinc deficiency pregnancy oral contraceptive pill use lymphoma acute and chronic inflammation (it is an acute-phase reactant) rheumatoid arthritis Angina Alzheimer's disease Schizophrenia Obsessive-compulsive disorder
Even before the war came to an end, it seemed highly likely that cooperation between the Western powers and the USSR would give way to intense rivalry or conflict. This was due primarily to the starkly contrasting economic ideologies of the two superpowers, now quite easily the strongest in the world. Whereas the US was a liberal, two-party democracy with an advanced capitalist economy, based on free enterprise and profit-making, the USSR was a one-party Marxist–Leninist State with a state-controlled economy where private wealth was all but outlawed. Nevertheless, the origins of the Cold War should also be seen as a historical episode that demarcated the spheres of interests of the United States and the Soviet Union.
Sources: en.wikipedia.org
The isoelectric point (pI, pH(I), IEP), is the pH at which a molecule carries no net electrical charge or is electrically neutral in the statistical mean. The standard nomenclature to represent the isoelectric point is pH(I). However, pI is also used. For brevity, this article uses pI. The net charge on the molecule is affected by pH of its surrounding environment and can become more positively or negatively charged due to the gain or loss, respectively, of protons (H+). Surfaces naturally charge to form a double layer. In the common case when the surface charge-determining ions are H+/HO−, the net surface charge is affected by the pH of the liquid in which the solid is submerged. The pI value can affect the solubility of a molecule at a given pH. Such molecules have minimum solubility in water or salt solutions at the pH that corresponds to their pI and often precipitate out of solution. Biological amphoteric molecules such as proteins contain both acidic and basic functional groups. Amino acids that make up proteins may be positive, negative, neutral, or polar in nature, and together give a protein its overall charge. At a pH below their pI, proteins carry a net positive charge; above their pI they carry a net negative charge. Proteins can, thus, be separated by net charge in a polyacrylamide gel using either preparative native PAGE, which uses a constant pH to separate proteins, or isoelectric focusing, which uses a pH gradient to separate proteins. Isoelectric focusing is the first step in 2-D polyacrylamide gel electrophoresis.
== Further reading == Chemically synthesized genes for human insulin Synthesis of customized petroleum-replica fuel molecules by targeted modification of free fatty acid pools in Escherichia coli Metabolic engineering of Saccharomyces cerevisiae for production of fatty acid short- and branched-chain alkyl esters biodiesel Ginkgo Bioworks featured work
Surrounded by Heroes: Six Campaigns with Division Headquarters, 82nd Airborne Division, 1942–1945. Drexel Hill, PA: Casemate, 2007. ISBN 1-932033-58-0 OCLC 124985055 LoFaro, Guy Sword of St. Michael: The 82nd Airborne Division in World War II. Cambridge, MA: Da Capo Press, 2011. ISBN 0-306-82023-4 OCLC 659768768 Lunteren, Frank van. The Battle of the Bridges: The 504th Parachute Infantry Regiment in Operation Market Garden. Philadelphia: Casemate Publishing, 2014. ISBN 978-1-61200-232-3 Lunteren, Frank van. Birth of a Regiment: The 504th Parachute Infantry Regiment in Sicily and Salerno. New York: Permuted Press, LLC, 2022. Lunteren, Frank van. Blocking Kampfgruppe Peiper: The 504th Parachute Infantry Regiment in the Batlle of the Bulge. Philadelphia: Casemate Publishing, 2015. Lunteren, Frank van. Spearhead of the Fifth Army: The 504th Parachute Infantry Regiment in Italy, from the Winter Line to Anzio. Philadelphia, Casemate Publishing, 2016. Marshall, S. L. A., Carl Sandburg, and H. Garver Miller. Night Drop: The American Airborne Invasion of Normandy. Boston: Little, Brown, 1962. OCLC 1260577 McCann, John P. Passing Through: The 82nd Airborne Division in Northern Ireland 1943–44. Newtownards, County Down, Northern Ireland: Colourpoint Books, 2005. ISBN 1-904242-41-3 OCLC 60883703 McKenzie, John D. On Time, on Target: The World War II Memoir of a Paratrooper in the 82nd Airborne. Novato, CA: Presidio Press, 2000. ISBN 0-89141-714-1 OCLC 42863044 McManus, John C. September Hope: The American Side of a Bridge Too Far. New York: New American Library, 2012.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.